Loading…
American Shared Hospital Services is projected to rise to $1.50 by 2027, a +1% move from its current price of $1.49. AMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.43 | $1.49 | $1.56 | +0.08% |
| May 30 | $1.40 | $1.49 | $1.59 | +0.15% |
| May 31 | $1.39 | $1.49 | $1.61 | +0.23% |
| Jun 1 | $1.37 | $1.49 | $1.63 | +0.30% |
| Jun 2 | $1.36 | $1.50 | $1.65 | +0.38% |
| Jun 3 | $1.35 | $1.50 | $1.66 | +0.46% |
| Jun 4 | $1.34 | $1.50 | $1.68 | +0.53% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.34 | $1.50 | $1.68 | +0.53% |
| Week 2 | $1.28 | $1.51 | $1.77 | +1.07% |
| Week 3 | $1.24 | $1.51 | $1.85 | +1.61% |
| Week 4 | $1.21 | $1.52 | $1.91 | +2.15% |
| Week 5 | $1.18 | $1.53 | $1.98 | +2.70% |
| Week 6 | $1.16 | $1.54 | $2.04 | +3.25% |
| Week 7 | $1.14 | $1.55 | $2.09 | +3.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
American Shared Hospital Services (AMS) is a healthcare company that provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments: Leasing and Direct Patient Service. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system, and provides planning, installation, reimbursement, and marketing support services.
It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
AMS is a healthcare stock with a current price of $1.49, a market cap of $9.87M, and a rank of 5106. The stock’s near-term outlook is driven by a year-by-year forecast that moves from Neutral to Bullish in later years. The forecast shows Neutral sentiment for 2026 through 2030, then Bullish sentiment beginning in 2031 and continuing thereafter.
The multi-year targets include a 2030 average price of $1.57 with a ROI of 5.3 and a 2040 average price of $3.41 with a ROI of 128.6, culminating in a 2050 average price of $5.20 with a ROI of 249.2.
A major floor 42.1% below — a decisive break under it would weaken the trend.
The nearest floor, 13.4% below — buyers have tended to step in here.
The nearest ceiling, 36.2% above — a clean break opens room to run.
A major ceiling 57.3% above — clearing it would confirm fresh momentum.
Key AMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.37 | Buy | $1.41 | Buy |
| MA 10 | $1.43 | Buy | $1.45 | Buy |
| MA 20 | $1.59 | Sell | $1.51 | Sell |
| MA 50 | $1.57 | Sell | $1.62 | Sell |
| MA 100 | $1.85 | Sell | $1.78 | Sell |
| MA 200 | $2.08 | Sell | $2.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.62 | Neutral |
| Stoch RSI (14) | 30.44 | Neutral |
| CCI (20) | -33.34 | Neutral |
| Williams %R (14) | -77.14 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -26.60 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 22.86 | Neutral |
| TRIX (15) | -0.18 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 47.64 | Neutral |
| Momentum (10) | -0.24 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 1.37 | Buy |
| ADX (14) | 24.78 | Sell |
| ATR (14) | 0.07 | Info |
The 30-day technical picture shows a Bearish sentiment overall, with RSI14 at 50. The stock trades with a SMA50 of $1.57 and a SMA200 of $2.08. Near-term support sits at $1.29 and resistance at $2.03. The 30-day range runs from $1.12 to $1.98, indicating a relatively tight trading band near the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.29 | $1.49 | $2.07 | 0% | Neutral | |
| $1.12 | $1.50 | $2.16 | +1% | Neutral | |
| $1.01 | $1.41 | $2.14 | -5% | Neutral | |
| $1.02 | $1.48 | $2.34 | 0% | Neutral | |
| $1.04 | $1.57 | $2.56 | +5% | Neutral | |
| $1.26 | $1.96 | $3.29 | +31% | Bullish | |
| $1.38 | $2.22 | $3.83 | +49% | Bullish | |
| $1.33 | $2.20 | $3.90 | +48% | Bullish | |
| $1.36 | $2.32 | $4.18 | +55% | Bullish | |
| $1.17 | $2.05 | $3.77 | +37% | Bullish | |
| $1.71 | $3.41 | $6.82 | +129% | Bullish | |
| $2.34 | $5.20 | $11.73 | +249% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.29 | $1.49 | $1.76 | +0.00% |
| June 2026 | $1.28 | $1.52 | $1.87 | +2.22% |
| July 2026 | $1.32 | $1.60 | $2.00 | +4.86% |
| August 2026 | $1.29 | $1.58 | $2.01 | -1.21% |
| September 2026 | $1.28 | $1.57 | $2.02 | -0.57% |
| October 2026 | $1.33 | $1.64 | $2.14 | +4.74% |
| November 2026 | $1.32 | $1.65 | $2.18 | +0.48% |
| December 2026 | $1.24 | $1.56 | $2.07 | -5.61% |
Click any year to see its month-by-month AMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AMS could reach as high as $2.07, with a base case around $1.49 and support toward $1.29 — roughly 0% from $1.49. Price action looks broadly range-bound.
Expect AMS to range from $1.12 to $2.16 through 2027. The $1.50 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. A consolidation phase looks the most probable path here.
The AMS price prediction for 2028 points to an average of $1.41 (low $1.01, high $2.14) — a potential decline of -5% on today's $1.49. Price action looks broadly range-bound.
In 2029, AMS is projected to trade between $1.02 and $2.34, averaging $1.48 — a potential decline of 0% from today's $1.49. That is up +5% on the projected 2028 average. A consolidation phase looks the most probable path here.
American Shared Hospital Services's 2030 outlook centres on $1.57, within a $1.04 to $2.56 range. That is up +6% on the projected 2029 average. That marks a +5% change versus current levels. Price action looks broadly range-bound.
By 2031, AMS could reach as high as $3.29, with a base case around $1.96 and support toward $1.26 — roughly +31% from $1.49. Buyers look set to stay in control over this stretch.
Expect AMS to range from $1.38 to $3.83 through 2032. The $2.22 average target implies a +49% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The AMS price prediction for 2033 points to an average of $2.20 (low $1.33, high $3.90) — a potential gain of +48% on today's $1.49. Buyers look set to stay in control over this stretch.
In 2034, AMS is projected to trade between $1.36 and $4.18, averaging $2.32 — a potential gain of +55% from today's $1.49. That is up +5% on the projected 2033 average. Momentum favours further upside here.
American Shared Hospital Services's 2035 outlook centres on $2.05, within a $1.17 to $3.77 range. That is -12% versus the projected 2034 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, AMS could reach as high as $6.82, with a base case around $3.41 and support toward $1.71 — roughly +129% from $1.49. Momentum favours further upside here.
Expect AMS to range from $2.34 to $11.73 through 2050. The $5.20 average target implies a +249% move from current prices. That is up +53% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in AMS today (≈ 671.14094 AMS) could be worth
$3,491.73
+$2,491.73 (+249%) by 2050 · US Dollar
Based on the average projected AMS price of $5.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMSwould be worth at today's price.
$1,000 invested in AMS on May 27, 2025 (≈ 420.168047 AMS) would be worth
$626.05
-$373.95 (-37.4%) today · 0.63× · US Dollar
Based on a AMS entry price of $2.38 vs. today's $1.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.33 | $1,120.3 | +12.0% |
| 1 month ago | $1.32 | $1,128.79 | +12.9% |
| 3 months ago | $2.14 | $696.26 | -30.4% |
| 6 months ago | $2.14 | $696.26 | -30.4% |
| 1 year ago | $2.38 | $626.05 | -37.4% |
| All time (5.0y) ago | $2.68 | $555.97 | -44.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMS forecast.
Our base-case forecast reaches $3.00 around 2040.
Implied market cap at $3.00: $19.88M
Over the multi-year horizon, the forecast shifts from Neutral in 2026–2030 to Bullish starting in 2031. The 2030 forecast shows an average price of $1.57 with ROI 5.3 and sentiment NEUTRAL, followed by a climb in the subsequent years. The 2031 average is $1.96 with ROI 31.4, and the 2032 average is $2.22 with ROI 49.1, continuing through 2033 at $2.20 (ROI 48) and 2034 at $2.32 (ROI 55.4), then 2035 at $2.05 (ROI 37.3).
The forecast accelerates toward the end of the decade and into 2040, with an average of $3.41 and ROI 128.6, and culminates in 2050 at an average $5.20 with ROI 249.2. The 2050 sentiment is BULLISH. These figures illustrate potential upside from 2031 onward, tempered by the inherent uncertainty of future markets.
Tap a question to reveal the answer.
In 2030, the forecast shows a min price of $1.04, an average price of $1.57, and a max price of $2.56, with ROI 5.3 and sentiment NEUTRAL.
Forecasts indicate Neutral sentiment through 2030, then Bullish from 2031 onward, with the average price rising to $1.96 in 2031 and $5.20 by 2050 and ROI reaching 249.2. These are estimates, not guarantees, and actual performance may differ.
Yes. The forecast shows a max price of $4.18 in 2034, with higher later-year maximums such as $6.82 in 2040 and $11.73 in 2050.
AMS trades at $1.49 per share with a market cap of $9.87M, and it ranks 5106.
The 30-day range was $1.12 to $1.98.
American Shared Hospital Services Community Discussion
0Share your American Shared Hospital Services price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.